• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双膦酸盐类药物的毒性。

Toxicity of bisphosphonates.

机构信息

Division of Hematology and Oncology, Mayo Clinic, Scottsdale, Arizona 85259, USA.

出版信息

J Palliat Med. 2009 Nov;12(11):1061-5. doi: 10.1089/jpm.2009.9936.

DOI:10.1089/jpm.2009.9936
PMID:19922007
Abstract

Bisphosphonates have become an important treatment for the palliation of metastatic bone disease. Their increasing use has lead to the recognition of toxicities that can lead to substantial morbidity for the patient with advanced cancer. This case presentation highlights toxicities associated with bisphosphonate use and provides some guidelines on the use of bisphosphonates and management of these toxicities.

摘要

双膦酸盐已成为缓解转移性骨病的重要治疗方法。随着其使用的增加,人们认识到其可能导致晚期癌症患者发生严重疾病。本病例介绍强调了与双膦酸盐使用相关的毒性,并提供了一些关于双膦酸盐使用和这些毒性管理的指导原则。

相似文献

1
Toxicity of bisphosphonates.双膦酸盐类药物的毒性。
J Palliat Med. 2009 Nov;12(11):1061-5. doi: 10.1089/jpm.2009.9936.
2
Bisphosphonate-induced osteonecrosis of the jaw.双膦酸盐诱导的颌骨坏死
Ann Pharmacother. 2007 Feb;41(2):276-84. doi: 10.1345/aph.1H521. Epub 2007 Feb 13.
3
Therapy insight: the risks and benefits of bisphosphonates for the treatment of tumor-induced bone disease.治疗洞察:双膦酸盐类药物治疗肿瘤诱导性骨病的风险与益处
Nat Clin Pract Oncol. 2007 Jan;4(1):42-55. doi: 10.1038/ncponc0688.
4
Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients.双膦酸盐治疗相关的无血管性下颌骨坏死:4例病例报告
Anticancer Res. 2007 Jul-Aug;27(4A):1841-5.
5
Complication related to bisphosphonate therapy: osteonecrosis of the jaw.双膦酸盐治疗相关并发症:颌骨坏死。
J Infus Nurs. 2009 Nov-Dec;32(6):330-5. doi: 10.1097/NAN.0b013e3181bd5373.
6
[Progress and problems in oral bisphosphonate].[口服双膦酸盐的进展与问题]
Clin Calcium. 2014 Jan;24(1):27-33.
7
[Osteonecrosis of the jaws and bisphosphonates].[颌骨骨坏死与双膦酸盐]
Rev Med Suisse. 2005 Nov 2;1(39):2537-40, 2542-3.
8
Bisphosphonate-related osteonecrosis of the jaw: an overview.双膦酸盐相关性颌骨坏死:概述。
Ann N Y Acad Sci. 2011 Feb;1218:38-46. doi: 10.1111/j.1749-6632.2010.05768.x. Epub 2010 Sep 28.
9
Skeletal complications and the use of bisphosphonates in metastatic prostate cancer.转移性前列腺癌中的骨骼并发症及双膦酸盐的应用
Int J Palliat Nurs. 2006 Oct;12(10):462-9. doi: 10.12968/ijpn.2006.12.10.22118.
10
Osteonecrosis of the jaw related to the use of bisphosphonates.与双膦酸盐类药物使用相关的颌骨骨坏死
Curr Opin Oncol. 2007 Jul;19(4):315-22. doi: 10.1097/CCO.0b013e32819f820b.

引用本文的文献

1
Promising efficacy of nitrogen-containing bisphosphonates against the infection of Cryptosporidium spp.含氮双膦酸盐对隐孢子虫属感染具有显著疗效。
Int J Parasitol Drugs Drug Resist. 2025 Aug 6;29:100607. doi: 10.1016/j.ijpddr.2025.100607.
2
Bisphosphonate conjugation for bone specific drug targeting.用于骨特异性药物靶向的双膦酸盐偶联
Bone Rep. 2018 Jul 3;9:47-60. doi: 10.1016/j.bonr.2018.06.007. eCollection 2018 Dec.
3
Patterns of bisphosphonate treatment among patients with multiple myeloma treated at oncology clinics across the USA: observations from real-world data.
美国肿瘤临床中多发性骨髓瘤患者双磷酸盐治疗模式:真实世界数据观察。
Support Care Cancer. 2018 Aug;26(8):2833-2841. doi: 10.1007/s00520-018-4133-1. Epub 2018 Mar 7.
4
Intravenous pamidronate versus oral and intravenous clodronate in bone metastatic breast cancer: a randomized, open-label, non-inferiority Phase III trial.静脉注射帕米膦酸盐与口服及静脉注射氯膦酸盐治疗骨转移性乳腺癌的比较:一项随机、开放标签、非劣效性III期试验。
Onco Targets Ther. 2016 Jul 8;9:4173-80. doi: 10.2147/OTT.S103130. eCollection 2016.
5
Vertebral compression fractures during chemotherapy for childhood acute lymphoblastic leukemia: commentary on a report from the STeroid Associated Osteoporosis in the Pediatric Population (STOPP) research program.儿童急性淋巴细胞白血病化疗期间的椎体压缩骨折:对儿科人群类固醇相关骨质疏松症(STOPP)研究项目一份报告的评论
Transl Pediatr. 2012 Oct;1(2):65-7. doi: 10.3978/j.issn.2224-4336.2012.09.04.
6
Side effects of bone-targeted therapies in advanced breast cancer.晚期乳腺癌骨靶向治疗的副作用。
Breast Care (Basel). 2014 Oct;9(5):332-6. doi: 10.1159/000368844.
7
Management of pain in the elderly at the end of life.终末期老年患者的疼痛管理。
Drugs Aging. 2012 Apr 1;29(4):285-305. doi: 10.2165/11599210-000000000-00000.
8
Targeting polymer therapeutics to bone.靶向聚合物治疗药物至骨骼。
Adv Drug Deliv Rev. 2012 Sep;64(12):1189-204. doi: 10.1016/j.addr.2012.01.012. Epub 2012 Jan 28.
9
Enhanced affinity bifunctional bisphosphonates for targeted delivery of therapeutic agents to bone.增强亲和力双功能双膦酸盐用于将治疗剂靶向递送至骨骼。
Bioconjug Chem. 2011 Dec 21;22(12):2496-506. doi: 10.1021/bc2003132. Epub 2011 Dec 5.
10
Enhanced anti-tumor activity and safety profile of targeted nano-scaled HPMA copolymer-alendronate-TNP-470 conjugate in the treatment of bone malignances.靶向纳米 HPMA 共聚物-阿仑膦酸盐-TNP-470 偶联物在治疗骨恶性肿瘤中的增强抗肿瘤活性和安全性。
Biomaterials. 2011 Jul;32(19):4450-63. doi: 10.1016/j.biomaterials.2011.02.059. Epub 2011 Mar 22.